Homburger

On January 15, 2026, UBS Switzerland AG successfully completed its issuance of CHF 150 m 0.435 per cent. Fixed Rate Covered Bonds due January 15, 2029, CHF 190 m 0.745 per cent. Fixed Rate Covered Bonds due January 15, 2032, and CHF 345 m 1.0225 per cent. Fixed Rate Covered Bonds due January 15, 2036, under its Covered Bond Programme. The Covered Bonds are governed by Swiss law and are listed on SIX Swiss Exchange. The Covered Bonds are indirectly backed by a portfolio of mortgages from UBS Switzerland AG’s domestic mortgage pool. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Daniel Hulmann, Yulia Shaburnykova (all Capital Markets), as well as Stefan Oesterhelt (Tax).

On January 26, 2026, Zürcher Kantonalbank successfully completed its issuance of EUR 500 m 2.950 per cent. Fixed Rate Bonds due January 26, 2031 (the Bonds). The senior unsecured Bonds have been issued under Zürcher Kantonalbank’s Swiss base prospectus consisting of the applicable summary and securities note for the issue of bonds and short term notes of Zürcher Kantonalbank dated June 20, 2025 and the registration form for debt securities dated June 20, 2025, as updated, approved by SIX Exchange Regulation AG and final terms issued thereunder. BNP PARIBAS, Deutsche Bank Aktiengesellschaft, UBS AG London Branch, and Zürcher Kantonalbank acted as the Joint Lead Managers. Homburger acted as counsel to Zürcher Kantonalbank as issuer. The Homburger team was led by Benjamin Leisinger and included Yulia Shaburnykova (both Capital Markets). Tax aspects were covered by Dieter Grünblatt.

January 23, 2026 Homburger acted as Swiss counsel to Fastned Tico Holding I B.V., a direct subsidiary of Fastned B.V., in its capacity as borrower in connection with a Dutch law-governed EUR 100 m committed senior multicurrency term facility agreement with an additional EUR 100 m option with a European lending syndicate consisting of ABN AMRO Bank N.V., Crédit Agricole Corporate and Investment Bank, ING Bank N.V., Invest-NL Capital N.V. and Coöperatieve Rabobank U.A. Fastned B.V. is a Europe-wide operator of electric fast-charging stations and listed at Euronext Amsterdam. The Homburger team was led by Daniel Hasler (Corporate / M&A) and included Jürg Frick (Financing), Jonas Stähli and Matthias Müller (both Corporate / M&A), Stefan Oesterhelt, Reto Heuberger and Laetitia Fracheboud (all Tax) as well as Gregor Bühler (IP/IT).     Contact Wanda Schweda / Marketing / [email protected]  

On January 15, 2026, HIAG Immobilien Holding AG, a leading player in the real estate industry in Switzerland that covers the entire property value chain of portfolio/asset management, site development and transaction management, placed CHF 100 m in aggregate principal amount of 1.340 percent Green Bonds due 2033 (the Green Bonds). Raiffeisen Schweiz Genossenschaft and Basler Kantonalbank acted as Joint Lead Managers. The Green Bonds will be listed on the SIX Swiss Exchange. Homburger advised Raiffeisen Schweiz Genossenschaft in the transaction. The Homburger team was led by Benjamin Leisinger (Capital Markets) and included Yulia Shaburnykova (Capital Markets). Contact Wanda Schweda / Marketing / [email protected]  

On January 13, 2026, UBS Group AG successfully completed its issuance of EUR 1.5 bn in aggregate principal amount of Fixed Rate/Fixed Rate Callable Senior Notes due February 2031 and EUR 1.5 bn in aggregate principal amount of Fixed Rate/Fixed Rate Callable Senior Notes due January 2037 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG’s Swiss gone concern capital requirement. The Notes are governed by Swiss law, and the Notes have been provisionally admitted to trading, and application will be made for definitive admission to trading and listing of the Notes, on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino, Olivier Baum and Daniel Hulmann (all Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On January 13, 2026, Baseline Wealth Management, an established FINMA-registered portfolio manager and SEC-registered investment advisor (RIA) with offices in Geneva and Zurich, announced it has joined Creative Planning, one of the largest RIAs in the United States. The transaction represents Creative Planning’s first international acquisition and underscores the attractivity of Baseline's experience serving international and U.S. clients. The acquisition adds more than USD 1 bn in assets under management to Creative Planning. The Homburger team was led by Frank Gerhard (Corporate / M&A) and included Romain Hondius, Thomas Romelli and Constantin Khovrin (all Corporate / M&A), Alexander Wherlock (Financial Market Regulation) and Philippe Weber (Tax).   Contact Gloria Pünchera / Marketing / [email protected]  

On January 8, 2026, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced that it had signed an exclusive licensing agreement with Nxera Pharma, a biopharmaceutical company listed on the Tokyo Stock Exchange, for the development, manufacturing and commercialization of AGAMREE® for the treatment of Duchenne muscular dystrophy in Japan, South Korea, Australia and New Zealand. Santhera will receive a USD 30 m cash upfront payment and a USD 10 m equity investment through the purchase of c. 530 k shares by Nxera at a 20 % premium to the 30-day VWAP. Homburger advises Santhera on the Swiss corporate, capital markets and financing aspects of the transaction. The Homburger team is led by Daniel Häusermann and includes Marco Rostetter (both Corporate / M&A, Capital Markets) and Eduard De Zordi (Financing, Investment Products, Capital Markets).

On 22 October 2025, FalconX and 21Shares announced to join forces by a merger by absorption by FalconX of 21Shares' ultimate parent company. The merger was effected in November 2025. FalconX is a leading digital assets prime brokerage providing comprehensive access to global digital asset liquidity and a full range of services to the world’s top institutions. The firm serves as a single point of access for trading, financing, custody, and direct market access (DMA) across spot, derivatives, and FX markets, supported by advanced technology and sophisticated risk management. 21Shares, through its Swiss offering vehicle 21Shares AG, offers one of the world's largest suite of cryptocurrency exchange-traded products (ETPs), making cryptocurrency investing more accessible. 21Shares will continue to operate as an independent company within the FalconX group, maintaining the same management team and brand. This acquisition strengthens the bridge between listed-market products and the crypto-native ecosystem at a time when digital assets are becoming increasingly institutionalized. Homburger AG advised 21Shares on various Swiss law- and Swiss tax-related matters in the preparation and implementation of the merger. The team was co-led by Margrit Marti (Corporate / M&A) and Benjamin Leisinger (Capital Markets / Financial Market Regulation) and included Stefan Oesterhelt, Reto Heuberger, Peter Müller, Philippe Gobet and Philippe Stiegeler (all Tax), Olivier Bühlmann and Carolina Rodriguez (both Corporate / M&A), Gregor Bühler (Data Protection and Employment), as well as Stefan Bindschedler and Simone Gloor (Financing). Contact Gloria Pünchera / Marketing / [email protected]  

On December 21, 2025, Windward Bio Group AG, a Swiss-based private, clinical-stage biotechnology company committed to improving outcomes for people living with advanced immunological diseases, announced a licensing agreement between its affiliate, LE2025 Therapeutics AG, and Qyuns Therapeutics Co., Ltd. for the development and commercialization of WIN027 (also known as QX027N), a potential best-in-disease, long-acting bispecific antibody targeting TSLP and IL-13. Under the terms of the agreement, Windward Bio will gain exclusive rights to develop, manufacture, and commercialize WIN027 outside of China, for a total of up to USD 700 m in upfront and equity consideration and development and commercial milestones, as well as tiered royalties. The Homburger team advising Windward Bio includes Andreas Müller, Margrit Marti, Timo Hasler and Lucas Forrer (all Healthcare / Life Sciences and Corporate / M&A), Stefan Oesterhelt and Juliette Buob (both Tax) and other subject matter specialists.     Contact Gloria Pünchera / Marketing / [email protected]  

On December 15, 2025, Swixx BioPharma AG announced the signing of an agreement for a strategic investment by SK Capital Partners. The investment values Swixx BioPharma at more than EUR 1.5 bn. Swixx BioPharma is a leading global full-service partner in the distribution of biopharmaceutical products operating across multiple countries in Central and Eastern Europe, Greece, Eurasia and several CIS countries, the Middle East and Latin America. Closing is expected in the second quarter of 2026, subject to customary regulatory approvals. After closing, SK Capital will become Swixx’s lead investor. Biocorp, together with the founders and other shareholders, including Mérieux Equity Partners and HBM Healthcare Investments, will reinvest alongside SK Capital. Homburger is acting as counsel to Biocorp, the founders of Laboratorios Biopas, which was acquired by Swixx BioPharma in summer 2024 and, as part of that transaction, became shareholders in Swixx BioPharma. The Homburger team includes Andreas Müller, Claude Lambert, Hans Glent Abildgaard (all Corporate / M&A) and other subject matter specialists.  

On December 12, 2025, Aris Mining Corporation (TSX: ARIS; NYSEA: ARMN) announced the completion of its acquisition of the remaining 49% interest in the Soto Norte joint venture in Colombia from MDC Industry Holding Company LLC (Mubadala). Aris Mining Corporation now owns 100% of the Soto Norte project, a high-grade, long-life underground gold project that incorporates industry-leading environmental and social design features. The Homburger team was led by Daniel Hasler (Corporate / M&A) and included Marco Rostetter (Corporate / M&A) as well as Jürg Frick (Financing).

On December 8, 2025, EQT announced the sale of an additional 10% stake in Galderma Group AG (SIX: GALD) by a consortium led by EQT, which includes Sunshine SwissCo GmbH (SSCO), Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as sellers) to L’Oréal S.A. for an undisclosed amount. Following the transaction, which is subject to customary regulatory approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The EQT-led consortium and L’Oréal agreed to customary provisions for an investment of this type. The previously concluded shareholder undertaking between SSCO and L’Oréal will be dissolved effective upon completion of the transaction. In connection with the increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal. Homburger acted as transaction counsel to EQT. The team was led by Frank Gerhard and Margrit Marti, and comprised Carlo Sulser, Estelle Piccard, Jannis Zafeirakos and Viviane Egli (all Corporate / M&A, Capital Markets), Stefan Oesterhelt and Laetitia Fracheboud (both Tax), Richard Stäuber and Giulia Meier (both Competition) as well as Micha Fankhauser (Financial Market Regulation).

Homburger AG acted as special Swiss counsel to UniCredit Bank GmbH in its capacity as mandated lead arranger in connection with the USD 1.1 bn borrowing base credit facilities. The facility includes an increase option to a total of USD 1.4 bn. UniCredit and ING acted as joint bookrunners and mandated lead arrangers. Sixteen other international syndicate banks are involved in the financing, including Commerzbank, Deutsche Bank, DZ Bank, Helaba, HSBC, LBBW, MUFG, NordLB and Rabobank. As a global coffee wholesaler, Neumann will use the funds to refinance and consolidate its existing financing agreements and to finance the general trading activities of the Neumann Group. Neumann Gruppe GmbH, based in Hamburg, is the holding company of the Neumann Kaffee Group, which comprises more than 40 companies in 28 countries and employs more than 3,300 people worldwide. The Homburger team was led by Daniel Haeberli (Financing) and included Simone Gloor and Céline Rüegg (both Financing) as well as Stefan Oesterhelt (Tax).   Contact Wanda Schweda / Marketing / [email protected]

On December 2, 2025, Roche Holdings, Inc. successfully completed its issuance of USD 1.9 bn in aggregate principal amount of senior notes, consisting of USD 500 m 4.075% notes due 2030, USD 600 m 4.374% notes due 2032 and USD 800 m 4.666% notes due 2035. The notes are irrevocably and unconditionally guaranteed by Roche Holding Ltd. The Homburger team was led by Jürg Frick (Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Dieter Grünblatt (Tax). Contact Wanda Schweda / Marketing / [email protected]  

On November 10, 2025, (i) UBS Group AG successfully completed its all-cash tender offers with respect to five series of bail-inable (TLAC) bonds that were originally issued by Credit Suisse Group AG, and (ii) UBS AG, acting through its Stamford branch, successfully completed its all-cash tender offers with respect to two series of senior unsecured notes that were originally issued by Credit Suisse AG, acting through its New York branch. UBS Group AG accepted tenders with respect to four series of such bail-inable (TLAC) bonds in an aggregate principal amount of USD 5.55 bn, and UBS AG, acting through its Stamford branch, accepted tenders in respect of both series of senior unsecured notes in an aggregate principal amount of USD 2.12 bn. The TLAC bonds repurchased by UBS Group AG were eligible to count towards UBS Group AG’s Swiss gone-concern requirement, governed by Swiss law and admitted to trading and listed on the SIX Swiss Exchange, and the notes repurchased by UBS AG, acting through its Stamford branch, were SEC-registered, governed by the laws of the State of New York and not admitted to trading or listed on any regulated trading venue. Homburger advised UBS Group AG and UBS AG with respect to all regulatory and transactional aspects of Swiss law. The Homburger team was led by Benedikt Maurenbrecher and Stefan Kramer and included Olivier Baum and Lee Saladino (all Capital Markets), as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On November 20, 2025, Flexion Robotics, a Zurich-based technology company, announced that it had raised USD 50 million in Series A funding from DST Global Partners, NVentures (NVIDIA's venture capital arm), redalpine, Prosus Ventures, and Moonfire. This funding allows Flexion Robotics to expand the Zurich R&D team, scale compute and robot fleets, establish a U.S. presence, and accelerate commercialization of its autonomy stack. The company is already working with major OEM partners, with the ambition to scale these partnerships globally. Homburger advised NVentures. The Homburger team comprised Andreas Müller, Margrit Marti and Lucas Forrer (all Corporate / M&A) as well as specialists. Contact Gloria Pünchera / Marketing / [email protected]

On November 21, 2025, UBS AG, acting through its London branch, successfully completed its issuance of EUR 750 m in aggregate principal amount of Floating Rate Notes due 2027 under its Euro Note Programme. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Stefan Oesterhelt (Tax).   Contact Wanda Schweda / Marketing / [email protected]  

On November 18, 2025, UBS AG, acting through its Stamford branch, successfully completed its issuance of USD 750 m in aggregate principal amount of Floating Rate Senior Notes due 2027 under its medium-term notes program. The notes were offered and sold in reliance on (i) an exemption from registration provided by Section 3(a)(2) of the U.S. Securities Act of 1933, as amended, and (ii) Section 16.6 of Part 16 of the regulations of the Office of the Comptroller of the Currency. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Stefan Oesterhelt (Tax).

Homburger advised Grant Thornton Advisors in its strategic initiative to expand its multinational platform through the acquisitions of Grant Thornton Switzerland and Grant Thornton Liechtenstein. This transaction – together with other recent expansions – creates a team of more than 18,000 professionals in offices stretching from the Americas across Europe and the Middle East to the Asia Pacific region. The transaction was backed by an investor group led by New Mountain Capital. The Homburger team was led by partner Dieter Gericke (Corporate / M&A) and included partners Benjamin Leisinger (Financial Services), Balz Gross (Employment and Executive Compensation) and Richard Stäuber (Competition) as well as associates Thierry Burckhardt, Cédric Berger, Hans Glent Abildgaard, Simone Schmid, Viviane Egli and Leon Indov (all Corporate / M&A), Kimberly Amrein (Employment and Executive Compensation), Giulia Meier (Competition) and Fabrice Eckert (Financial Services). Contact Wanda Schweda / Marketing / [email protected]

On November 4, 2025, CDR-Life and Boehringer Ingelheim announced a new global licensing agreement to develop CDR-Life’s unique antibody-based molecule CDR111 for autoimmune diseases. The agreement builds on the companies’ successful collaboration on an investigational antibody fragment. Under the terms of the agreement, CDR-Life is eligible for up to a total of CHF 456 m in payments, including CHF 38 m in upfront and near-term payments, plus tiered royalties on future sales. Homburger acted as counsel to CDR-Life AG. The Homburger team was led by Luca Dal Molin (IP / IT) and included Richard Stäuber (Regulatory) and Joel Fink (IP / IT). Contact Wanda Schweda / Marketing / [email protected]